Cargando…
Salinomycin Potentiates the Cytotoxic Effects of TRAIL on Glioblastoma Cell Lines
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been reported to exhibit therapeutic activity in cancer. However, many tumors remain resistant to treatment with TRAIL. Therefore, small molecules that potentiate the cytotoxic effects of TRAIL could be used for combinatorial therap...
Autores principales: | Calzolari, Alessia, Saulle, Ernestina, De Angelis, Maria Laura, Pasquini, Luca, Boe, Alessandra, Pelacchi, Federica, Ricci-Vitiani, Lucia, Baiocchi, Marta, Testa, Ugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989199/ https://www.ncbi.nlm.nih.gov/pubmed/24740347 http://dx.doi.org/10.1371/journal.pone.0094438 |
Ejemplares similares
-
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide
por: Tentori, Lucio, et al.
Publicado: (2014) -
A Small Molecule SMAC Mimic LBW242 Potentiates TRAIL- and Anticancer Drug-Mediated Cell Death of Ovarian Cancer Cells
por: Petrucci, Eleonora, et al.
Publicado: (2012) -
PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response
por: Saulle, Ernestina, et al.
Publicado: (2016) -
Salinomycin-loaded Nanofibers for Glioblastoma Therapy
por: Norouzi, Mohammad, et al.
Publicado: (2018) -
Salinomycin-Loaded Iron Oxide Nanoparticles for Glioblastoma Therapy
por: Norouzi, Mohammad, et al.
Publicado: (2020)